Therapeutic Indications

Carbocisteine is indicated for:

Viscid mucoid secretions

Irrespective of gender only Children (1 year - 12 years old)

Carbocisteine is a mucolytic agent for the adjunctive therapy of respiratory tract disorders characterised by excessive, viscous mucus, including chronic obstructive airways disease. 2

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 180-750 mg in three separated doses daily

Viscid mucoid secretions

Irrespective of gender only Adolescents (12 years - 18 years old) , Adults (18 - 65 years old)

Carbocisteine is a mucolytic agent for the adjunctive therapy of respiratory tract disorders characterised by excessive, viscous mucus, including chronic obstructive airways disease. 2

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 1500-2250mg daily

Contraindications

Active ingredient Carbocisteine is contraindicated in the following cases:

Active peptic ulceration

No gender/age discrimination

Carbocisteine is contraindicated in patients with active peptic ulceration. Caution is recommended in the elderly, in those with a history of gastroduodenal ulcers, or those taking concomitant medications known to cause gastrointestinal bleeding. Since mucolytics may disrupt the gastric mucosal barrier, caution should be taken in patients with a history of peptic ulcers. If gastrointestinal bleeding occurs, patients should discontinue medication.